Krsnaa Diagnostics share price
You have to be logged in to add this to Watchlist.- ₹732.00(-1.98%)April 30, 2025 15:45:26 PM IST
- NSE
- BSE
- Vol : 68.91K (NSE + BSE)Last 20 day avg : 82.61 K
Krsnaa Diagnostics is trading -1.98% lower at Rs 732.00 as compared to its last closing price. Krsnaa Diagnostics has been trading in the price range of 753.70 & 726.80. Krsnaa Diagnostics has given -15.68% in this year & -5.06% in the last 5 days. Krsnaa Diagnostics has TTM P/E ratio 37.85 as compared to the sector P/E of 22.89.There are 2 analysts who have initiated coverage on Krsnaa Diagnostics. There are 2 analysts who have given it a strong buy rating & 0.00 analysts have given it a buy rating. 0.00 analysts have given the stock a sell rating.The company posted a net profit of 19.42 Crores in its last quarter.Listed peers of Krsnaa Diagnostics include Indraprastha Medical Corp (-1.42%), Artemis Medicare Services (-0.79%), Krsnaa Diagnostics (-1.98%).The Mutual Fund holding in Krsnaa Diagnostics was at 9.36% in 31 Mar 2025. The MF holding has decreased from the last quarter. The FII holding in Krsnaa Diagnostics was at 3.55% in 31 Mar 2025. The FII holding has decreased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
- 1 D
- 5 D
- 1 M
- 3 M
- 6 M
- 1 Y
- 5 Y
- MAX
Updated on Apr 30, 2025, 01:44 PM UTC
- Dividend YieldLower than industry0.33Annual dividends as a percentage of the stock price.
- P/BHigher than historical values2.98The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- P/EHigher than historical values32.73Price-to-earnings ratio based on trailing 12-month earnings
- BetaLow volatility0.24Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityHigher than industry0.20The debt-to-equity ratio, indicating a company's financial leverage.
- PEG Ratio-The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
|
| ||||
|
| ||||
- Income
- Balance Sheet
- Cash Flow
- Financial
- Valuation
Company is profitable- The company's revenue grew in December quarter by 10.23% from Rs 174.51 crore to Rs 158.32 crore, year-on-year
- The company has grown its December quarter profit by 49.65% from Rs 12.97 crore to Rs 19.42 crore, year-on-year
The debt to equity of the company is higher than the industry median- Company can comfortably pay off its interest obligations with its earnings
- R1
- 852.20
- R2
- 919.00
- R3
- 1,003.10
- S1
- 701.30
- S2
- 617.20
- S3
- 550.40
- Very Bearish
- Bearish
- Neutral
- Very Bullish
- Bullish
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Indraprastha Medical Corp | Bearish | 397.10 | -1.42 | 3,638.98 | 30.49 | 7.97 | 1.08 | 6.75 |
| Artemis Medicare Services | Bearish | 257.75 | -0.79 | 3,574.79 | 75.06 | 8 | 0.17 | 63.85 |
| Krsnaa Diagnostics | Bearish | 732.00 | -1.98 | 2,363.61 | 43.40 | 3 | 0.33 | 5.17 |
| Shalby | Bearish | 189.55 | -0.42 | 2,047.86 | 24.23 | 2.03 | 0.63 | 22.68 |
| Dr. Agarwal's Eye Hospital | Bearish | 4,111.00 | -2.22 | 1,936.23 | 42.50 | 12.58 | 0.12 | 157.84 |
- Promoter(s) does not have a high stake in the company
- Promoter(s) have increased the stake in the company in last 12 months
- FIIs are invested in this company
- FIIs holding has decreased by 0.49 percentage points from previous quarter
- Mutual Funds holding has decreased by 0.46 percentage points from previous quarter
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2025-02-12 | Quarterly Results |
| 2024-10-25 | Quarterly Results |
| 2024-08-06 | Quarterly Results |
| 2024-05-18 | Audited Results & Final Dividend |
| 2024-02-12 | Quarterly Results |
- IndustryHealthcare Facilities
- ISININE08LI01020
- BSE Code543328
- NSE CodeKRSNAA
Krsnaa Diagnostics is trading at 732.00 as on Wed Apr 30 2025 10:15:26. This is -1.98% lower as compared to its previous closing price of 746.80.
The market capitalization of Krsnaa Diagnostics is 2363.61 Cr as on Wed Apr 30 2025 10:15:26.
The average broker rating on Krsnaa Diagnostics is Strong Buy. The breakup of analyst rating is given below -
- 2 analysts have given a strong buy rating
- 0.00 analysts have given a buy rating
- 0.00 analysts have given a hold rating
- 0.00 analysts have given a sell rating
- 0.00 analysts have given a strong sell rating
The 52 wk high for Krsnaa Diagnostics is 1041.80 whereas the 52 wk low is 527.55
Krsnaa Diagnostics can be analyzed on the following key metrics -
- TTM P/E: 37.85
- Sector P/E: 22.89
- Dividend Yield: 0.33%
- D/E ratio: -
Krsnaa Diagnostics reported a net profit of 56.84 Cr in 2024.
The Mutual Fund Shareholding was 9.36% at the end of 31 Mar 2025.